Sheel Biotech IPO
GMP, Subscription, Price, Dates & Financial Details
Agriculture
Sheel Biotech Limited Incorporated in November 1991, Sheel Biotech Limited is engaged in biotechnology, floriculture, greenhouse solutions, and organic farming projects. The company leverages advanced technologies such as tissue culture, hydroponics, and modern farming systems to deliver…
Open Date
Tue, 30 Sep 2025
Close Date
Fri, 03 Oct 2025
Price Band
₹ 59 – 63
Lot Size
2000
Issue Size
₹ 34.02 Cr
Minimum Investment
₹ 252,000 (4000 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Sheel Biotech IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹34.02 Crore.
The Sheel Biotech IPO remained open for subscription from September 30, 2025, to October 03, 2025. The basis of allotment was finalized on October 06, 2025, and the company's shares were listed on NSE SME Platform on October 08, 2025.
The company had fixed the price band at ₹59 to ₹63 per share, with a lot size of 2000 shares. Retail investors were required to make a minimum investment of ₹252,000 (based on the upper price band) to apply for one lot.
Skyline Financial Services Private Ltd served as the registrar to the issue. Narnolia Financial Services acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Sheel Biotech Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Sheel Biotech IPO Timeline (Tentative)
- IPO Open Date
- Tue, 30 Sep 25
- IPO Close Date
- Fri, 03 Oct 25
- Basis of Allotment
- Mon, 06 Oct 25
- Initiation of Refunds
- Tue, 07 Oct 25
- Credit of Shares to Demat
- Tue, 07 Oct 25
- Listing Date
- Wed, 08 Oct 25 — NSE & BSE
Open Date
30 September 2025
Close Date
03 October 2025
Basis Of Allotment
06 October 2025
Listing Date
08 October 2025
IPO Subscription
Check Live Subscription →The Sheel Biotech IPO has received bids for 5,78,56,000 shares against 36,04,000 shares offered, resulting in an overall subscription of 16.05x. the NII category is subscribed 26.29x, Retail Investors 9.57x, and QIBs 19.73x. Within the NII category, BNII is subscribed 32.16x, while SNII is subscribed 14.56x.
QIB
19.73x
NII
26.29x
BNII
32.16x
SNII
14.56x
RII
9.57x
Total
16.05x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 18,04,000 shares, representing 50.06% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 10,26,000 shares (28.47%), while Non-Institutional Investors (NIIs) receive 7,74,000 shares (21.48%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,026,000 | 28.47% |
| Non-Institutional | 774,000 | 21.48% |
| BNII | 516,000 | 14.32% |
| SNII | 258,000 | 7.16% |
| Retail Investors | 1,804,000 | 50.06% |
| Total | 3,604,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 113.28 | 105.95 | 93.89 |
| Revenue | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.51 | 5.08 |
| Net Worth | 83.85 | 72.73 | 63.54 |
| Reserve & Surplus | 68.9 | 68.58 | 59.4 |
| Total Borrowings | 17.36 | 23.54 | 19.17 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Sheel Biotech Limited KPI Information
| Particular | KPI as of Mon |
|---|---|
| ROE % | 13.59 |
| ROCE % | 16.34 |
| Debt / Equity | 0.32 |
| RoNW % | 13.59 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Sheel Biotech Limited | 10 | 0.00 | 7.21 | 7.21 | 13.59 | 56.84 |
| Jain Irrigation System Ltd | 2 | 143.97 | 0.36 | 0.36 | 0.50 | 72.07 |
| Vrundavan Plantation Ltd | 10 | 14.24 | 3.30 | 3.30 | 7.39 | 44.63 |
About Sheel Biotech Limited
Sheel Biotech Limited
Incorporated in November 1991, Sheel Biotech Limited is engaged in biotechnology, floriculture, greenhouse solutions, and organic farming projects. The company leverages advanced technologies such as tissue culture, hydroponics, and modern farming systems to deliver sustainable agricultural solutions.
Operations and Offerings
- Planting Material: Production and supply of high-quality, disease-free planting materials for fruits, vegetables, floriculture, forestry, and ornamental plants using tissue culture and hydroponics.
- Horticultural Projects: Design and implementation of turnkey projects including greenhouses, centers of excellence, integrated packhouses, and other facilities. These projects incorporate advanced systems such as climate control, automation, drip irrigation, and fertigation to enhance yield and quality.
- Organic Adoption & Certification: Assistance to farmers in transitioning to organic practices through adoption and certification services aligned with the National Programme for Organic Production (NPOP) and the Participatory Guarantee System (PGS).
- Farmer Producer Organization (FPO) Management: Support for establishing and managing FPOs, offering training, skill development, and market linkages to improve farmer access to quality inputs and services.
- Skill Development & Training: Organization of training programs, workshops, seminars, and exposure visits to equip farmers and agripreneurs with modern agricultural knowledge and practices.
- Landscaping Services: Delivery of landscaping solutions for both government and private sector projects.
Certifications & Recognition
- Certified under ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, affirming its commitment to quality, environmental sustainability, and occupational safety.
- Operates an R&D laboratory recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST), Government of India.
Workforce
As of September 30, 2024, the company employed 160 permanent employees.
Sheel Biotech IPO Promoters
- Dr. Satya Narayan Chandak
- Mr. Sanjay Chandak
- Mr. Divye Chandak
- Mrs. Mini Chadha
- M/s Satya Narayan Chandak (HUF)
- M/s Sanjay Chandak (HUF)
- M/s Sumeet Chandak (HUF)
Promoters Holding
Holding Pre Issue
96.99%
Holding Post Issue
71.26%
Sheel Biotech IPO Objective
The Company Sheel Biotech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure Requirement
- Working Capital Expenditure Requirement
- General Corporate Purposes
Sheel Biotech Limited Address / Contact Details
Sheel Biotech Ltd.
8 Balaji Estates
, 2nd Floor, Block-C, Guru Ravidas Marg
Kalkaji
South Delhi, New Delhi, 110019
Phone: +91 88511 - 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/
IPO Snapshot
Sheel Biotech IPO Lot Size
The Sheel Biotech IPO has a lot size of 2,000 shares. Retail investors require a minimum investment of ₹2,52,000 by applying for 2 lot (4,000 shares). The maximum application allowed for the retail category is 2 lots (4,000 shares), requiring an investment of ₹2,52,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | 252,000.00 |
| Retail (Max) | 2 | 4,000 | 252,000.00 |
| S-HNI (Min) | 3 | 6,000 | 378,000.00 |
| S-HNI (Max) | 7 | 14,000 | 882,000.00 |
| B-HNI (Min) | 8 | 16,000 | 1,008,000.00 |
Issue Reservation
- QIB — 28.47%
- NII — 21.48%
- RII — 50.06%
Book Running Lead Managers
- Narnolia Financial Services
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Sheel Biotech IPO?
Sheel Biotech IPO is a Book-building IPO with a total issue size of ₹34.02 crore. The Sheel Biotech IPO price band is ₹59 to 63 per share. The Sheel Biotech IPO subscription opens on Tue, Sep 30, 2025, and closes on Fri, Oct 3, 2025. The Sheel Biotech IPO will be listed on the NSE. Skyline Financial Services Private Ltd is the registrar for the Sheel Biotech IPO.
When will the Sheel Biotech IPO open for subscription?
The Sheel Biotech IPO opens on Tue, Sep 30, 2025 and closes on Fri, Oct 3, 2025
What is Sheel Biotech IPO Price Band?
Sheel Biotech IPO Price Band is ₹59 to 63 per share.
What is Sheel Biotech IPO Lot Size?
Sheel Biotech IPO lot size is 2000 shares, Retail investors need a minimum investment of ₹252000 based on the upper price band
What is the minimum investment for Sheel Biotech IPO?
The minimum investment for Sheel Biotech IPO is ₹252000, based on one lot of 2000 shares at the upper price band of ₹63 per share.
How to apply for Sheel Biotech IPO?
Investors can apply for the Sheel Biotech IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Oct 3, 2025. The application amount remains blocked until the Sheel Biotech IPO allotment is finalized.
What is Sheel Biotech IPO Issue Size?
Sheel Biotech IPO issue size is ₹34.02 crores.
What is the Sheel Biotech IPO Allotment Date?
Sheel Biotech IPO allotment date is Mon, Oct 6, 2025.
Who is the Sheel Biotech IPO Registrar?
The registrar for Sheel Biotech IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Sheel Biotech IPO allotment status, refund processing, and other IPO-related information.
What is the Sheel Biotech IPO GMP?
The Sheel Biotech IPO GMP (Grey Market Premium) is ₹16 as of Wed, Oct 8, 2025. Based on the upper price band of ₹63 per share, the estimated Sheel Biotech IPO listing price is ₹79, indicating a potential listing gain of approximately 25.40% over the issue price.
Who is the Sheel Biotech IPO Lead Manager?
The book-running lead managers (BRLMs) for the Sheel Biotech IPO are Narnolia Financial Services. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Sheel Biotech IPO Red Herring Prospectus (RHP).